SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-24-041819
Filing Date
2024-04-04
Accepted
2024-04-04 16:20:03
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-04

Document Format Files

Seq Description Document Type Size
1 ARS rgnx-ars-2023.pdf ARS 1390750
  Complete submission text file 0000950170-24-041819.txt   1915602
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-37553 | Film No.: 24823364
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)